Clinical Trials Directory

Trials / Completed

CompletedNCT02026492

Exercise Challenge in a Cold Chamber

Exercise-induced Bronchoconstriction in a Cold Chamber Compared to Methacholine Challenge

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
79 (actual)
Sponsor
Johann Wolfgang Goethe University Hospital · Academic / Other
Sex
All
Age
6 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the exercise-challenge in a cold chamber at 2-4°C to the gold standard the metacholine challenge in subjects showing symptoms of exercise-induced bronchoconstriction. The sensitivity and repeatability of the exercise test will be measured.

Detailed description

Subjects suffering form exercise-induced bronchoconstriction (EIB) usually have a normal lung function testing at rest. To provoke asthma symptoms a provocation test is necessary, e.g., by bronchial methacholine testing or by a standardised exercise test on a treadmill. The correlation between methacholine and exercise test is fair, possibly because both methods measure different kinds of bronchial hyperresponsiveness. Moreover, the sensitivity and the repeatability of the exercise test is fair. The value of the methacholine test to predict a positive exercise test will be measured. We hypothesize that the exercise test in a cold chamber, a combination of two provocation methods cold air and exercise, is more sensitive to detect EIB and that the test has a better repeatability.

Conditions

Interventions

TypeNameDescription
OTHERExercise challenge in a cold chamberExercise challenge is defined as running on a treadmill for 6-8 minutes on submaximal work load in a cold chamber.
OTHERMethacholine challengenebulized metacholine administered at following doses: 0,01mg, 0,1mg, 0,4mg, 0,8mg und 1,6mg
OTHERExercise challenge in room temperatureExercise challenge is defined as running on a treadmill for 6-8 minutes on submaximal work load in room temperature.

Timeline

Start date
2013-06-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2014-01-03
Last updated
2015-03-17

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02026492. Inclusion in this directory is not an endorsement.